There is an A-share company that produces uridine, 600668 Jianfeng Group.
Shanghai North Carolina Pharmaceuticals, a subsidiary of Jianfeng Group, produces Merck’s MoInupiravir API, uridine, and Pfizer’s paxlovid API, Carsonic Anhydride. One of the raw materials of Merck's new coronavirus oral medicine is uridine, and one of the raw materials of Pfizer's new coronavirus oral medicine is caronic anhydride. Only North Carolina, a subsidiary of Jianfeng Group, has both raw materials in the A-share market! ! ! Taken together, peak valuations are ridiculously low. Shanghai Biocompounds Pharmaceutical Inc., a subsidiary controlled by Jianfeng Group, focuses on small molecule targeted generic platforms and produces a variety of APIs and pharmaceutical intermediates.